12 March 1999
Evidence that Human Haematopoietic Stem Cells( HSC) do not Reside within the CD34+KIT- Cell Population
Janina Ratajczak, Boguslaw Machalinski, Marcin Majka, Jacek Kijowski, Wojciech Marlicz, Tomasz Rozmyslowicz, Marek Ostrowski, Mariusz Z RatajczakAnn Transplant 1999; 4(1): 22-30 :: ID: 497436
Abstract
Contradictory reports are published concerning the c-kit receptor (KIT) expression on human haematopoietic stem cells (HHSC). Therefore, the aim of this study was to reevaluate the expression of KIT on human early haematopoietic cells. and to study the distribution of HHSC among bone marrow mononuclear KIT+ and KIT-cells. First, we found that the detection sensitivity of the KITexpression on human HELcells as well as CD34+ depends on the type of fluorochrome employed for the immunostaining (Cy5 > PE> FITC). Based on this observation, in our strategy for isolating human HHSCwe employed a Cy-5 conjugated a-KIT MoAbs, which stained CD34+ cells in our preliminary studies the brightest. Accordingly, we labeled human BMMNC with PE-a-CD34 and Cy5-a-KIT MoAbs and subsequently sorted various subsets of labeled cells (CD34 +KIT+, CD34 +KIT and CD34-KIT-). Cells sorted by FACS were then evaluated for their ability to engraft in the immunodeficient SCID mice model. We report here that only CD34+KIT+ cells, but not CD34+KIT or CD34-KIT were able to establish a human-murine haematopoietic chimerism in these animals. We found that SCID mice transplanted with CD34 +KIT+ cells, possessed - 5-11%ofmononuclear cells, which expressed human CD45 antigen 4-5 weeks after transplantation in their bone marrow and, more importantly, early human haematopoietic progenitors from the myeloid and B-Iymphoid lineages. Based on these results we conclude that KIT(CD 117) is a very useful marker for identifying HHSC, and that HHSC, at least in our hands, are found in the KIT+ population of CD34+ cells.
Keywords: KIT receptor, SCID mice, CD34+ cells, haematopoietic stem cells
In Press
15 Mar 2024 : Review article
Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighti...Ann Transplant In Press; DOI: 10.12659/AOT.941185
18 Mar 2024 : Original article
Does Antibiotic Use Increase the Risk of Post-Transplantation Diabetes Mellitus? A Retrospective Study of R...Ann Transplant In Press; DOI: 10.12659/AOT.943282
20 Mar 2024 : Original article
Transplant Nephrectomy: A Comparative Study of Timing and Techniques in a Single InstitutionAnn Transplant In Press; DOI: 10.12659/AOT.942252
28 Mar 2024 : Original article
Association Between FEV₁ Decline Rate and Mortality in Long-Term Follow-Up of a 21-Patient Pilot Clinical T...Ann Transplant In Press; DOI: 10.12659/AOT.942823
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860